Skip to main content
. 2018 Aug 24;2(4):360–370. doi: 10.7150/ntno.27142

Figure 1.

Figure 1

The synthetic pathway for development of the hyperbranched polymer based theranostic nanomedicine incorporating either A8 (HBP/A8/DOX) or A13 (HBP/A13/DOX).